Bionano Genomics, Inc.(BNGO)— Stock Profile, AI Score & Financials

Technology · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Bionano Genomics, Inc. (BNGO) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores BNGO at 12.6/100 on a 32-signal composite quality model, placing it at rank #2,887 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (3.3) and revenue scale (5.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 11.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Bionano Genomics, Inc. reports quarterly revenue of $8.2M, net income of $-7.4M, an operating margin of -88.3%. Top institutional holders of BNGO by reported 13-F value include GSA CAPITAL PARTNERS LLP, CARRET ASSET MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. BNGO trades on the Nasdaq exchange and files with the SEC under CIK 1411690. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BNGO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bionano Genomics, Inc. directly from SEC EDGAR.